NCP Management Co., 15 Elmer St, Cambridge, MA 02138, US

HiFiBiO Therapeutics is a clinical-stage global biotech company based in Cambridge, MA. They are dedicated to revolutionizing the development of immunotherapies by utilizing their unique high-resolution translational platform, DIS, which provides an unprecedented understanding of immune dysregulation at the single cell level. Their goal is to enhance the probability of success for immunotherapies and improve patient outcomes through single-cell precision. With a focus on single cell science, HiFiBiO Therapeutics applies this approach at every stage of drug development, from target discovery to predictive biomarkers. This enables them to rapidly advance new therapeutics into the clinic, ultimately aiming to unlock the curative powers of the immune system. Through strategic collaborations and groundbreaking initiatives, they are at the forefront of personalized immunotherapies and have been recognized for their innovative Drug Intelligence Science (DIS) platform.Generated from the website